通过向siRNA输送和顺序化疗来促进乳腺癌免疫疗法
Naghmeh Jabarimani1, Ehsan Khabazian1,2, Bahar Morshedi1
1Department of Pharmaceutics, Tehran University of Medical Sciences, Tehran, Iran.
Journal of drug targeting
|July 11, 2025
概括
这项研究开发了新的纳米粒子,用于传递向PD-L1的siRNA,在与帕克利塔塞尔化疗相结合时增强乳腺癌免疫疗法. 组合疗法显著提高了抗瘤免疫力,并抑制了小鼠的瘤生长.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫治疗是一种免疫疗法.
背景情况:
- 由于治疗耐药性和发病率上升,癌症带来了重大挑战.
- 反编程细胞死亡配体1 (PD-L1) 免疫疗法显示出有希望的结果,但作为单一疗法的有效性有限.
- 将化疗与免疫疗法结合使用可以改善治疗结果并减少副作用.
研究的目的:
- 开发一种新的纳米粒子系统,用于传递PD-L1 siRNA.
- 研究帕克利塔塞尔和PD-L1 siRNA治疗在乳腺癌中的协同效应.
- 为了提高抗PD-L1免疫疗法的疗效.
主要方法:
- 开发用于siRNA输送的三甲基基托 (TMC) 和氨酸 (HA) 纳米粒子.
- 纳米粒子物理化学性质的表征,包括尺寸,封装效率,稳定性和细胞吸收.
- 在4T1小鼠模型中,对帕克利塔塞尔和PD-L1siRNA纳米颗粒的连续施用.
主要成果:
- 开发了具有高siRNA封装,稳定性和癌细胞内部化能力的球形纳米粒子 (~190nm).
- 与单一治疗相比,与帕克利塔塞尔和PD-L1siRNA的连续治疗显著抑制了瘤生长.
- 在瘤微环境中观察到增强的抗瘤免疫力和增加的CD8+T细胞透.
结论:
- 新型TMC/HA纳米粒子有效地传递PD-L1siRNA.
- 联合帕克利塔塞尔和PD-L1siRNA疗法代表了增强乳腺癌免疫疗法的有前途的策略.
- 这种方法可以增强抗瘤免疫力,并减少瘤的进展.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.8K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
